In an 88-year-old man with a six-month history of gross hematuria and right-sided flank pain, urinalysis showing numerous red blood cells, proteinuria, impaired renal function (estimated glomerular filtration rate ≈48 mL/min/1.73 m²), thrombocytopenia (platelet count 86 ×10⁹/L), and a remote history of kidney stones, what is the most appropriate next step in evaluation?

Urgent Urology Referral with CT Urography

This 88-year-old man with six months of gross hematuria and flank pain requires immediate urologic evaluation with cystoscopy and CT urography, as gross hematuria carries a 30-40% risk of malignancy regardless of his history of kidney stones or thrombocytopenia. 1, 2

Why This Cannot Wait

The American College of Physicians explicitly states that all adults with gross hematuria should be referred for urologic evaluation, even if self-limited 1. The ACR Appropriateness Criteria reinforces that gross hematuria has a malignancy association of 30-40%, making full urologic workup mandatory 2. His six-month duration makes this even more concerning—this is not a transient finding.

Key Risk Factors Present

This patient has multiple high-risk features for urinary tract malignancy:

• Male gender
• Age >35 years (he's 88)
• Gross hematuria with flank pain
• Duration of symptoms (6 months is prolonged)

2

The Thrombocytopenia Does Not Change Management

Guideline evidence is clear: pursue evaluation of hematuria even if the patient is receiving antiplatelet or anticoagulant therapy 1. While his platelet count of 86 is low, this represents mild thrombocytopenia and does not obviate the need for cancer evaluation. The thrombocytopenia itself may be related to an underlying malignancy and requires concurrent hematologic workup, but should not delay urologic investigation.

Specific Next Steps

Immediate Actions:

1. Urgent urology referral for cystoscopy to evaluate the bladder and lower urinary tract 1, 2

2. CT urography as the imaging modality of choice, which should include:

   • Unenhanced phase (to detect stones and baseline renal assessment)
   • Nephrographic phase (to evaluate renal masses and parenchymal disease)
   • Excretory phase (to assess urothelial abnormalities throughout the collecting system)

   2, 3

3. Do NOT obtain urinary cytology in the initial evaluation—guidelines explicitly recommend against urine-based molecular markers for bladder cancer detection at this stage 1

Addressing the Renal Impairment

His eGFR of 48 mL/min/1.73 m² represents Stage 3 CKD. While this raises concerns about contrast administration, the imperative to exclude malignancy takes precedence. CT urography can be performed with appropriate hydration protocols and consideration of reduced contrast doses. The proteinuria (2+) and impaired renal function may indicate concurrent renal parenchymal disease, but this should not preclude urologic evaluation 2.

Common Pitfall to Avoid

Do not attribute the hematuria solely to his kidney stone history. While nephrolithiasis is a common benign cause of hematuria, the classic presentation of stones is acute renal colic with hematuria—not six months of persistent gross hematuria. The ACR guidelines note that while stones are common, the prolonged nature and gross character of his hematuria mandate full malignancy workup regardless of stone history 2.

The flank pain could represent:

• Urothelial carcinoma causing obstruction
• Renal cell carcinoma
• Stone disease (less likely given chronicity)
• Upper tract urothelial pathology

Only imaging and cystoscopy can differentiate these.

Why CT Urography Over Other Modalities

CT urography has become the single examination that can comprehensively evaluate gross hematuria, replacing the need for multiple separate tests 3. It provides:

• Superior detection of renal masses
• Excellent visualization of the collecting system and ureters
• Identification of stones
• Assessment of surrounding structures

MR urography could be considered if contrast CT is absolutely contraindicated, but CT remains the gold standard for this indication 2.